Global Recombinant Human GM-CSF for Injection Supply, Demand and Key Producers, 2023-2029
The global Recombinant Human GM-CSF for Injection market size is expected to reach $ 113.6 million by 2029, rising at a market growth of 3.6% CAGR during the forecast period (2023-2029).
Recombinant Human GM-CSF for Injection is a crucial biopharmaceutical product widely used in the treatment of various diseases, particularly leukemia and malignant tumors. The market for this product is substantial and continuously expanding, driven by advancements in medical technology and therapeutic approaches. In the future, it is expected that this field will continue to evolve, with specific uses of recombinant human GM-CSF potentially extending to include the treatment of more cancer types, offering further growth opportunities in the biopharmaceutical industry.
Recombinant Human GM-CSF for Injection is a biopharmaceutical product that plays a critical role in stimulating the growth and function of granulocytes and macrophages, key components of the immune system. It is used to treat various medical conditions, including neutropenia, leukemia, and as an adjunct therapy for certain cancer treatments. The market for this product is substantial, driven by the rising prevalence of diseases that compromise the immune system and the development of immunotherapies. Its future development is likely to involve expanded applications in immune-related therapies, further improving patient outcomes in the treatment of various disorders.
This report studies the global Recombinant Human GM-CSF for Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Human GM-CSF for Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Human GM-CSF for Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant Human GM-CSF for Injection total production and demand, 2018-2029, (K Units)
Global Recombinant Human GM-CSF for Injection total production value, 2018-2029, (USD Million)
Global Recombinant Human GM-CSF for Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human GM-CSF for Injection consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Human GM-CSF for Injection domestic production, consumption, key domestic manufacturers and share
Global Recombinant Human GM-CSF for Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Human GM-CSF for Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human GM-CSF for Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Recombinant Human GM-CSF for Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Changchun GeneScience, Hainan Unipul Pharmaceutical, Harbin Pharmaceutical Group and Guangzhou Baiyunshan Baidi Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Human GM-CSF for Injection market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Recombinant Human GM-CSF for Injection Market, By Region:
1. How big is the global Recombinant Human GM-CSF for Injection market?
2. What is the demand of the global Recombinant Human GM-CSF for Injection market?
3. What is the year over year growth of the global Recombinant Human GM-CSF for Injection market?
4. What is the production and production value of the global Recombinant Human GM-CSF for Injection market?
5. Who are the key producers in the global Recombinant Human GM-CSF for Injection market?
Recombinant Human GM-CSF for Injection is a crucial biopharmaceutical product widely used in the treatment of various diseases, particularly leukemia and malignant tumors. The market for this product is substantial and continuously expanding, driven by advancements in medical technology and therapeutic approaches. In the future, it is expected that this field will continue to evolve, with specific uses of recombinant human GM-CSF potentially extending to include the treatment of more cancer types, offering further growth opportunities in the biopharmaceutical industry.
Recombinant Human GM-CSF for Injection is a biopharmaceutical product that plays a critical role in stimulating the growth and function of granulocytes and macrophages, key components of the immune system. It is used to treat various medical conditions, including neutropenia, leukemia, and as an adjunct therapy for certain cancer treatments. The market for this product is substantial, driven by the rising prevalence of diseases that compromise the immune system and the development of immunotherapies. Its future development is likely to involve expanded applications in immune-related therapies, further improving patient outcomes in the treatment of various disorders.
This report studies the global Recombinant Human GM-CSF for Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Human GM-CSF for Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Human GM-CSF for Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant Human GM-CSF for Injection total production and demand, 2018-2029, (K Units)
Global Recombinant Human GM-CSF for Injection total production value, 2018-2029, (USD Million)
Global Recombinant Human GM-CSF for Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human GM-CSF for Injection consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Human GM-CSF for Injection domestic production, consumption, key domestic manufacturers and share
Global Recombinant Human GM-CSF for Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Human GM-CSF for Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human GM-CSF for Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Recombinant Human GM-CSF for Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Changchun GeneScience, Hainan Unipul Pharmaceutical, Harbin Pharmaceutical Group and Guangzhou Baiyunshan Baidi Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Human GM-CSF for Injection market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Recombinant Human GM-CSF for Injection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 75ug
- 150ug
- Hospital
- Clinic
- Others
- Sanofi
- Changchun GeneScience
- Hainan Unipul Pharmaceutical
- Harbin Pharmaceutical Group
- Guangzhou Baiyunshan Baidi Biotechnology
1. How big is the global Recombinant Human GM-CSF for Injection market?
2. What is the demand of the global Recombinant Human GM-CSF for Injection market?
3. What is the year over year growth of the global Recombinant Human GM-CSF for Injection market?
4. What is the production and production value of the global Recombinant Human GM-CSF for Injection market?
5. Who are the key producers in the global Recombinant Human GM-CSF for Injection market?
1 SUPPLY SUMMARY
1.1 Recombinant Human GM-CSF for Injection Introduction
1.2 World Recombinant Human GM-CSF for Injection Supply & Forecast
1.2.1 World Recombinant Human GM-CSF for Injection Production Value (2018 & 2022 & 2029)
1.2.2 World Recombinant Human GM-CSF for Injection Production (2018-2029)
1.2.3 World Recombinant Human GM-CSF for Injection Pricing Trends (2018-2029)
1.3 World Recombinant Human GM-CSF for Injection Production by Region (Based on Production Site)
1.3.1 World Recombinant Human GM-CSF for Injection Production Value by Region (2018-2029)
1.3.2 World Recombinant Human GM-CSF for Injection Production by Region (2018-2029)
1.3.3 World Recombinant Human GM-CSF for Injection Average Price by Region (2018-2029)
1.3.4 North America Recombinant Human GM-CSF for Injection Production (2018-2029)
1.3.5 Europe Recombinant Human GM-CSF for Injection Production (2018-2029)
1.3.6 China Recombinant Human GM-CSF for Injection Production (2018-2029)
1.3.7 Japan Recombinant Human GM-CSF for Injection Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Human GM-CSF for Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Human GM-CSF for Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Recombinant Human GM-CSF for Injection Demand (2018-2029)
2.2 World Recombinant Human GM-CSF for Injection Consumption by Region
2.2.1 World Recombinant Human GM-CSF for Injection Consumption by Region (2018-2023)
2.2.2 World Recombinant Human GM-CSF for Injection Consumption Forecast by Region (2024-2029)
2.3 United States Recombinant Human GM-CSF for Injection Consumption (2018-2029)
2.4 China Recombinant Human GM-CSF for Injection Consumption (2018-2029)
2.5 Europe Recombinant Human GM-CSF for Injection Consumption (2018-2029)
2.6 Japan Recombinant Human GM-CSF for Injection Consumption (2018-2029)
2.7 South Korea Recombinant Human GM-CSF for Injection Consumption (2018-2029)
2.8 ASEAN Recombinant Human GM-CSF for Injection Consumption (2018-2029)
2.9 India Recombinant Human GM-CSF for Injection Consumption (2018-2029)
3 WORLD RECOMBINANT HUMAN GM-CSF FOR INJECTION MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant Human GM-CSF for Injection Production Value by Manufacturer (2018-2023)
3.2 World Recombinant Human GM-CSF for Injection Production by Manufacturer (2018-2023)
3.3 World Recombinant Human GM-CSF for Injection Average Price by Manufacturer (2018-2023)
3.4 Recombinant Human GM-CSF for Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Human GM-CSF for Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Human GM-CSF for Injection in 2022
3.5.3 Global Concentration Ratios (CR8) for Recombinant Human GM-CSF for Injection in 2022
3.6 Recombinant Human GM-CSF for Injection Market: Overall Company Footprint Analysis
3.6.1 Recombinant Human GM-CSF for Injection Market: Region Footprint
3.6.2 Recombinant Human GM-CSF for Injection Market: Company Product Type Footprint
3.6.3 Recombinant Human GM-CSF for Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant Human GM-CSF for Injection Production Value Comparison
4.1.1 United States VS China: Recombinant Human GM-CSF for Injection Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Recombinant Human GM-CSF for Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Recombinant Human GM-CSF for Injection Production Comparison
4.2.1 United States VS China: Recombinant Human GM-CSF for Injection Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Recombinant Human GM-CSF for Injection Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Recombinant Human GM-CSF for Injection Consumption Comparison
4.3.1 United States VS China: Recombinant Human GM-CSF for Injection Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Recombinant Human GM-CSF for Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Recombinant Human GM-CSF for Injection Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Recombinant Human GM-CSF for Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Human GM-CSF for Injection Production Value (2018-2023)
4.4.3 United States Based Manufacturers Recombinant Human GM-CSF for Injection Production (2018-2023)
4.5 China Based Recombinant Human GM-CSF for Injection Manufacturers and Market Share
4.5.1 China Based Recombinant Human GM-CSF for Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Human GM-CSF for Injection Production Value (2018-2023)
4.5.3 China Based Manufacturers Recombinant Human GM-CSF for Injection Production (2018-2023)
4.6 Rest of World Based Recombinant Human GM-CSF for Injection Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Recombinant Human GM-CSF for Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Human GM-CSF for Injection Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Recombinant Human GM-CSF for Injection Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant Human GM-CSF for Injection Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 75ug
5.2.2 150ug
5.3 Market Segment by Type
5.3.1 World Recombinant Human GM-CSF for Injection Production by Type (2018-2029)
5.3.2 World Recombinant Human GM-CSF for Injection Production Value by Type (2018-2029)
5.3.3 World Recombinant Human GM-CSF for Injection Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Recombinant Human GM-CSF for Injection Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Recombinant Human GM-CSF for Injection Production by Application (2018-2029)
6.3.2 World Recombinant Human GM-CSF for Injection Production Value by Application (2018-2029)
6.3.3 World Recombinant Human GM-CSF for Injection Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Recombinant Human GM-CSF for Injection Product and Services
7.1.4 Sanofi Recombinant Human GM-CSF for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 Changchun GeneScience
7.2.1 Changchun GeneScience Details
7.2.2 Changchun GeneScience Major Business
7.2.3 Changchun GeneScience Recombinant Human GM-CSF for Injection Product and Services
7.2.4 Changchun GeneScience Recombinant Human GM-CSF for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Changchun GeneScience Recent Developments/Updates
7.2.6 Changchun GeneScience Competitive Strengths & Weaknesses
7.3 Hainan Unipul Pharmaceutical
7.3.1 Hainan Unipul Pharmaceutical Details
7.3.2 Hainan Unipul Pharmaceutical Major Business
7.3.3 Hainan Unipul Pharmaceutical Recombinant Human GM-CSF for Injection Product and Services
7.3.4 Hainan Unipul Pharmaceutical Recombinant Human GM-CSF for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Hainan Unipul Pharmaceutical Recent Developments/Updates
7.3.6 Hainan Unipul Pharmaceutical Competitive Strengths & Weaknesses
7.4 Harbin Pharmaceutical Group
7.4.1 Harbin Pharmaceutical Group Details
7.4.2 Harbin Pharmaceutical Group Major Business
7.4.3 Harbin Pharmaceutical Group Recombinant Human GM-CSF for Injection Product and Services
7.4.4 Harbin Pharmaceutical Group Recombinant Human GM-CSF for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.4.6 Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
7.5 Guangzhou Baiyunshan Baidi Biotechnology
7.5.1 Guangzhou Baiyunshan Baidi Biotechnology Details
7.5.2 Guangzhou Baiyunshan Baidi Biotechnology Major Business
7.5.3 Guangzhou Baiyunshan Baidi Biotechnology Recombinant Human GM-CSF for Injection Product and Services
7.5.4 Guangzhou Baiyunshan Baidi Biotechnology Recombinant Human GM-CSF for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Guangzhou Baiyunshan Baidi Biotechnology Recent Developments/Updates
7.5.6 Guangzhou Baiyunshan Baidi Biotechnology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Recombinant Human GM-CSF for Injection Industry Chain
8.2 Recombinant Human GM-CSF for Injection Upstream Analysis
8.2.1 Recombinant Human GM-CSF for Injection Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Human GM-CSF for Injection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Human GM-CSF for Injection Production Mode
8.6 Recombinant Human GM-CSF for Injection Procurement Model
8.7 Recombinant Human GM-CSF for Injection Industry Sales Model and Sales Channels
8.7.1 Recombinant Human GM-CSF for Injection Sales Model
8.7.2 Recombinant Human GM-CSF for Injection Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Recombinant Human GM-CSF for Injection Introduction
1.2 World Recombinant Human GM-CSF for Injection Supply & Forecast
1.2.1 World Recombinant Human GM-CSF for Injection Production Value (2018 & 2022 & 2029)
1.2.2 World Recombinant Human GM-CSF for Injection Production (2018-2029)
1.2.3 World Recombinant Human GM-CSF for Injection Pricing Trends (2018-2029)
1.3 World Recombinant Human GM-CSF for Injection Production by Region (Based on Production Site)
1.3.1 World Recombinant Human GM-CSF for Injection Production Value by Region (2018-2029)
1.3.2 World Recombinant Human GM-CSF for Injection Production by Region (2018-2029)
1.3.3 World Recombinant Human GM-CSF for Injection Average Price by Region (2018-2029)
1.3.4 North America Recombinant Human GM-CSF for Injection Production (2018-2029)
1.3.5 Europe Recombinant Human GM-CSF for Injection Production (2018-2029)
1.3.6 China Recombinant Human GM-CSF for Injection Production (2018-2029)
1.3.7 Japan Recombinant Human GM-CSF for Injection Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Human GM-CSF for Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Human GM-CSF for Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Recombinant Human GM-CSF for Injection Demand (2018-2029)
2.2 World Recombinant Human GM-CSF for Injection Consumption by Region
2.2.1 World Recombinant Human GM-CSF for Injection Consumption by Region (2018-2023)
2.2.2 World Recombinant Human GM-CSF for Injection Consumption Forecast by Region (2024-2029)
2.3 United States Recombinant Human GM-CSF for Injection Consumption (2018-2029)
2.4 China Recombinant Human GM-CSF for Injection Consumption (2018-2029)
2.5 Europe Recombinant Human GM-CSF for Injection Consumption (2018-2029)
2.6 Japan Recombinant Human GM-CSF for Injection Consumption (2018-2029)
2.7 South Korea Recombinant Human GM-CSF for Injection Consumption (2018-2029)
2.8 ASEAN Recombinant Human GM-CSF for Injection Consumption (2018-2029)
2.9 India Recombinant Human GM-CSF for Injection Consumption (2018-2029)
3 WORLD RECOMBINANT HUMAN GM-CSF FOR INJECTION MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant Human GM-CSF for Injection Production Value by Manufacturer (2018-2023)
3.2 World Recombinant Human GM-CSF for Injection Production by Manufacturer (2018-2023)
3.3 World Recombinant Human GM-CSF for Injection Average Price by Manufacturer (2018-2023)
3.4 Recombinant Human GM-CSF for Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Human GM-CSF for Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Human GM-CSF for Injection in 2022
3.5.3 Global Concentration Ratios (CR8) for Recombinant Human GM-CSF for Injection in 2022
3.6 Recombinant Human GM-CSF for Injection Market: Overall Company Footprint Analysis
3.6.1 Recombinant Human GM-CSF for Injection Market: Region Footprint
3.6.2 Recombinant Human GM-CSF for Injection Market: Company Product Type Footprint
3.6.3 Recombinant Human GM-CSF for Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant Human GM-CSF for Injection Production Value Comparison
4.1.1 United States VS China: Recombinant Human GM-CSF for Injection Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Recombinant Human GM-CSF for Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Recombinant Human GM-CSF for Injection Production Comparison
4.2.1 United States VS China: Recombinant Human GM-CSF for Injection Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Recombinant Human GM-CSF for Injection Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Recombinant Human GM-CSF for Injection Consumption Comparison
4.3.1 United States VS China: Recombinant Human GM-CSF for Injection Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Recombinant Human GM-CSF for Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Recombinant Human GM-CSF for Injection Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Recombinant Human GM-CSF for Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Human GM-CSF for Injection Production Value (2018-2023)
4.4.3 United States Based Manufacturers Recombinant Human GM-CSF for Injection Production (2018-2023)
4.5 China Based Recombinant Human GM-CSF for Injection Manufacturers and Market Share
4.5.1 China Based Recombinant Human GM-CSF for Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Human GM-CSF for Injection Production Value (2018-2023)
4.5.3 China Based Manufacturers Recombinant Human GM-CSF for Injection Production (2018-2023)
4.6 Rest of World Based Recombinant Human GM-CSF for Injection Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Recombinant Human GM-CSF for Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Human GM-CSF for Injection Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Recombinant Human GM-CSF for Injection Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant Human GM-CSF for Injection Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 75ug
5.2.2 150ug
5.3 Market Segment by Type
5.3.1 World Recombinant Human GM-CSF for Injection Production by Type (2018-2029)
5.3.2 World Recombinant Human GM-CSF for Injection Production Value by Type (2018-2029)
5.3.3 World Recombinant Human GM-CSF for Injection Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Recombinant Human GM-CSF for Injection Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Recombinant Human GM-CSF for Injection Production by Application (2018-2029)
6.3.2 World Recombinant Human GM-CSF for Injection Production Value by Application (2018-2029)
6.3.3 World Recombinant Human GM-CSF for Injection Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Recombinant Human GM-CSF for Injection Product and Services
7.1.4 Sanofi Recombinant Human GM-CSF for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 Changchun GeneScience
7.2.1 Changchun GeneScience Details
7.2.2 Changchun GeneScience Major Business
7.2.3 Changchun GeneScience Recombinant Human GM-CSF for Injection Product and Services
7.2.4 Changchun GeneScience Recombinant Human GM-CSF for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Changchun GeneScience Recent Developments/Updates
7.2.6 Changchun GeneScience Competitive Strengths & Weaknesses
7.3 Hainan Unipul Pharmaceutical
7.3.1 Hainan Unipul Pharmaceutical Details
7.3.2 Hainan Unipul Pharmaceutical Major Business
7.3.3 Hainan Unipul Pharmaceutical Recombinant Human GM-CSF for Injection Product and Services
7.3.4 Hainan Unipul Pharmaceutical Recombinant Human GM-CSF for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Hainan Unipul Pharmaceutical Recent Developments/Updates
7.3.6 Hainan Unipul Pharmaceutical Competitive Strengths & Weaknesses
7.4 Harbin Pharmaceutical Group
7.4.1 Harbin Pharmaceutical Group Details
7.4.2 Harbin Pharmaceutical Group Major Business
7.4.3 Harbin Pharmaceutical Group Recombinant Human GM-CSF for Injection Product and Services
7.4.4 Harbin Pharmaceutical Group Recombinant Human GM-CSF for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.4.6 Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
7.5 Guangzhou Baiyunshan Baidi Biotechnology
7.5.1 Guangzhou Baiyunshan Baidi Biotechnology Details
7.5.2 Guangzhou Baiyunshan Baidi Biotechnology Major Business
7.5.3 Guangzhou Baiyunshan Baidi Biotechnology Recombinant Human GM-CSF for Injection Product and Services
7.5.4 Guangzhou Baiyunshan Baidi Biotechnology Recombinant Human GM-CSF for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Guangzhou Baiyunshan Baidi Biotechnology Recent Developments/Updates
7.5.6 Guangzhou Baiyunshan Baidi Biotechnology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Recombinant Human GM-CSF for Injection Industry Chain
8.2 Recombinant Human GM-CSF for Injection Upstream Analysis
8.2.1 Recombinant Human GM-CSF for Injection Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Human GM-CSF for Injection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Human GM-CSF for Injection Production Mode
8.6 Recombinant Human GM-CSF for Injection Procurement Model
8.7 Recombinant Human GM-CSF for Injection Industry Sales Model and Sales Channels
8.7.1 Recombinant Human GM-CSF for Injection Sales Model
8.7.2 Recombinant Human GM-CSF for Injection Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Recombinant Human GM-CSF for Injection Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Recombinant Human GM-CSF for Injection Production Value by Region (2018-2023) & (USD Million)
Table 3. World Recombinant Human GM-CSF for Injection Production Value by Region (2024-2029) & (USD Million)
Table 4. World Recombinant Human GM-CSF for Injection Production Value Market Share by Region (2018-2023)
Table 5. World Recombinant Human GM-CSF for Injection Production Value Market Share by Region (2024-2029)
Table 6. World Recombinant Human GM-CSF for Injection Production by Region (2018-2023) & (K Units)
Table 7. World Recombinant Human GM-CSF for Injection Production by Region (2024-2029) & (K Units)
Table 8. World Recombinant Human GM-CSF for Injection Production Market Share by Region (2018-2023)
Table 9. World Recombinant Human GM-CSF for Injection Production Market Share by Region (2024-2029)
Table 10. World Recombinant Human GM-CSF for Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Recombinant Human GM-CSF for Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Recombinant Human GM-CSF for Injection Major Market Trends
Table 13. World Recombinant Human GM-CSF for Injection Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Recombinant Human GM-CSF for Injection Consumption by Region (2018-2023) & (K Units)
Table 15. World Recombinant Human GM-CSF for Injection Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Recombinant Human GM-CSF for Injection Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Human GM-CSF for Injection Producers in 2022
Table 18. World Recombinant Human GM-CSF for Injection Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Recombinant Human GM-CSF for Injection Producers in 2022
Table 20. World Recombinant Human GM-CSF for Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Recombinant Human GM-CSF for Injection Company Evaluation Quadrant
Table 22. World Recombinant Human GM-CSF for Injection Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Recombinant Human GM-CSF for Injection Production Site of Key Manufacturer
Table 24. Recombinant Human GM-CSF for Injection Market: Company Product Type Footprint
Table 25. Recombinant Human GM-CSF for Injection Market: Company Product Application Footprint
Table 26. Recombinant Human GM-CSF for Injection Competitive Factors
Table 27. Recombinant Human GM-CSF for Injection New Entrant and Capacity Expansion Plans
Table 28. Recombinant Human GM-CSF for Injection Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Human GM-CSF for Injection Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Recombinant Human GM-CSF for Injection Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Recombinant Human GM-CSF for Injection Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Recombinant Human GM-CSF for Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Human GM-CSF for Injection Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Human GM-CSF for Injection Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Recombinant Human GM-CSF for Injection Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Recombinant Human GM-CSF for Injection Production Market Share (2018-2023)
Table 37. China Based Recombinant Human GM-CSF for Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Human GM-CSF for Injection Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Recombinant Human GM-CSF for Injection Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Recombinant Human GM-CSF for Injection Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Recombinant Human GM-CSF for Injection Production Market Share (2018-2023)
Table 42. Rest of World Based Recombinant Human GM-CSF for Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Human GM-CSF for Injection Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Human GM-CSF for Injection Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Recombinant Human GM-CSF for Injection Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant Human GM-CSF for Injection Production Market Share (2018-2023)
Table 47. World Recombinant Human GM-CSF for Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Recombinant Human GM-CSF for Injection Production by Type (2018-2023) & (K Units)
Table 49. World Recombinant Human GM-CSF for Injection Production by Type (2024-2029) & (K Units)
Table 50. World Recombinant Human GM-CSF for Injection Production Value by Type (2018-2023) & (USD Million)
Table 51. World Recombinant Human GM-CSF for Injection Production Value by Type (2024-2029) & (USD Million)
Table 52. World Recombinant Human GM-CSF for Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Recombinant Human GM-CSF for Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Recombinant Human GM-CSF for Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Recombinant Human GM-CSF for Injection Production by Application (2018-2023) & (K Units)
Table 56. World Recombinant Human GM-CSF for Injection Production by Application (2024-2029) & (K Units)
Table 57. World Recombinant Human GM-CSF for Injection Production Value by Application (2018-2023) & (USD Million)
Table 58. World Recombinant Human GM-CSF for Injection Production Value by Application (2024-2029) & (USD Million)
Table 59. World Recombinant Human GM-CSF for Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Recombinant Human GM-CSF for Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Recombinant Human GM-CSF for Injection Product and Services
Table 64. Sanofi Recombinant Human GM-CSF for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. Changchun GeneScience Basic Information, Manufacturing Base and Competitors
Table 68. Changchun GeneScience Major Business
Table 69. Changchun GeneScience Recombinant Human GM-CSF for Injection Product and Services
Table 70. Changchun GeneScience Recombinant Human GM-CSF for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Changchun GeneScience Recent Developments/Updates
Table 72. Changchun GeneScience Competitive Strengths & Weaknesses
Table 73. Hainan Unipul Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Hainan Unipul Pharmaceutical Major Business
Table 75. Hainan Unipul Pharmaceutical Recombinant Human GM-CSF for Injection Product and Services
Table 76. Hainan Unipul Pharmaceutical Recombinant Human GM-CSF for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Hainan Unipul Pharmaceutical Recent Developments/Updates
Table 78. Hainan Unipul Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 80. Harbin Pharmaceutical Group Major Business
Table 81. Harbin Pharmaceutical Group Recombinant Human GM-CSF for Injection Product and Services
Table 82. Harbin Pharmaceutical Group Recombinant Human GM-CSF for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Harbin Pharmaceutical Group Recent Developments/Updates
Table 84. Guangzhou Baiyunshan Baidi Biotechnology Basic Information, Manufacturing Base and Competitors
Table 85. Guangzhou Baiyunshan Baidi Biotechnology Major Business
Table 86. Guangzhou Baiyunshan Baidi Biotechnology Recombinant Human GM-CSF for Injection Product and Services
Table 87. Guangzhou Baiyunshan Baidi Biotechnology Recombinant Human GM-CSF for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 88. Global Key Players of Recombinant Human GM-CSF for Injection Upstream (Raw Materials)
Table 89. Recombinant Human GM-CSF for Injection Typical Customers
Table 90. Recombinant Human GM-CSF for Injection Typical Distributors
LIST OF FIGURE
Figure 1. Recombinant Human GM-CSF for Injection Picture
Figure 2. World Recombinant Human GM-CSF for Injection Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Recombinant Human GM-CSF for Injection Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Recombinant Human GM-CSF for Injection Production (2018-2029) & (K Units)
Figure 5. World Recombinant Human GM-CSF for Injection Average Price (2018-2029) & (US$/Unit)
Figure 6. World Recombinant Human GM-CSF for Injection Production Value Market Share by Region (2018-2029)
Figure 7. World Recombinant Human GM-CSF for Injection Production Market Share by Region (2018-2029)
Figure 8. North America Recombinant Human GM-CSF for Injection Production (2018-2029) & (K Units)
Figure 9. Europe Recombinant Human GM-CSF for Injection Production (2018-2029) & (K Units)
Figure 10. China Recombinant Human GM-CSF for Injection Production (2018-2029) & (K Units)
Figure 11. Japan Recombinant Human GM-CSF for Injection Production (2018-2029) & (K Units)
Figure 12. Recombinant Human GM-CSF for Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 15. World Recombinant Human GM-CSF for Injection Consumption Market Share by Region (2018-2029)
Figure 16. United States Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 17. China Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 18. Europe Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 19. Japan Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 20. South Korea Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 22. India Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Recombinant Human GM-CSF for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Human GM-CSF for Injection Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Human GM-CSF for Injection Markets in 2022
Figure 26. United States VS China: Recombinant Human GM-CSF for Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Recombinant Human GM-CSF for Injection Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Recombinant Human GM-CSF for Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Recombinant Human GM-CSF for Injection Production Market Share 2022
Figure 30. China Based Manufacturers Recombinant Human GM-CSF for Injection Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Recombinant Human GM-CSF for Injection Production Market Share 2022
Figure 32. World Recombinant Human GM-CSF for Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Recombinant Human GM-CSF for Injection Production Value Market Share by Type in 2022
Figure 34. 75ug
Figure 35. 150ug
Figure 36. World Recombinant Human GM-CSF for Injection Production Market Share by Type (2018-2029)
Figure 37. World Recombinant Human GM-CSF for Injection Production Value Market Share by Type (2018-2029)
Figure 38. World Recombinant Human GM-CSF for Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Recombinant Human GM-CSF for Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Recombinant Human GM-CSF for Injection Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Others
Figure 44. World Recombinant Human GM-CSF for Injection Production Market Share by Application (2018-2029)
Figure 45. World Recombinant Human GM-CSF for Injection Production Value Market Share by Application (2018-2029)
Figure 46. World Recombinant Human GM-CSF for Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Recombinant Human GM-CSF for Injection Industry Chain
Figure 48. Recombinant Human GM-CSF for Injection Procurement Model
Figure 49. Recombinant Human GM-CSF for Injection Sales Model
Figure 50. Recombinant Human GM-CSF for Injection Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Table 1. World Recombinant Human GM-CSF for Injection Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Recombinant Human GM-CSF for Injection Production Value by Region (2018-2023) & (USD Million)
Table 3. World Recombinant Human GM-CSF for Injection Production Value by Region (2024-2029) & (USD Million)
Table 4. World Recombinant Human GM-CSF for Injection Production Value Market Share by Region (2018-2023)
Table 5. World Recombinant Human GM-CSF for Injection Production Value Market Share by Region (2024-2029)
Table 6. World Recombinant Human GM-CSF for Injection Production by Region (2018-2023) & (K Units)
Table 7. World Recombinant Human GM-CSF for Injection Production by Region (2024-2029) & (K Units)
Table 8. World Recombinant Human GM-CSF for Injection Production Market Share by Region (2018-2023)
Table 9. World Recombinant Human GM-CSF for Injection Production Market Share by Region (2024-2029)
Table 10. World Recombinant Human GM-CSF for Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Recombinant Human GM-CSF for Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Recombinant Human GM-CSF for Injection Major Market Trends
Table 13. World Recombinant Human GM-CSF for Injection Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Recombinant Human GM-CSF for Injection Consumption by Region (2018-2023) & (K Units)
Table 15. World Recombinant Human GM-CSF for Injection Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Recombinant Human GM-CSF for Injection Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Human GM-CSF for Injection Producers in 2022
Table 18. World Recombinant Human GM-CSF for Injection Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Recombinant Human GM-CSF for Injection Producers in 2022
Table 20. World Recombinant Human GM-CSF for Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Recombinant Human GM-CSF for Injection Company Evaluation Quadrant
Table 22. World Recombinant Human GM-CSF for Injection Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Recombinant Human GM-CSF for Injection Production Site of Key Manufacturer
Table 24. Recombinant Human GM-CSF for Injection Market: Company Product Type Footprint
Table 25. Recombinant Human GM-CSF for Injection Market: Company Product Application Footprint
Table 26. Recombinant Human GM-CSF for Injection Competitive Factors
Table 27. Recombinant Human GM-CSF for Injection New Entrant and Capacity Expansion Plans
Table 28. Recombinant Human GM-CSF for Injection Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Human GM-CSF for Injection Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Recombinant Human GM-CSF for Injection Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Recombinant Human GM-CSF for Injection Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Recombinant Human GM-CSF for Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Human GM-CSF for Injection Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Human GM-CSF for Injection Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Recombinant Human GM-CSF for Injection Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Recombinant Human GM-CSF for Injection Production Market Share (2018-2023)
Table 37. China Based Recombinant Human GM-CSF for Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Human GM-CSF for Injection Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Recombinant Human GM-CSF for Injection Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Recombinant Human GM-CSF for Injection Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Recombinant Human GM-CSF for Injection Production Market Share (2018-2023)
Table 42. Rest of World Based Recombinant Human GM-CSF for Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Human GM-CSF for Injection Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Human GM-CSF for Injection Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Recombinant Human GM-CSF for Injection Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant Human GM-CSF for Injection Production Market Share (2018-2023)
Table 47. World Recombinant Human GM-CSF for Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Recombinant Human GM-CSF for Injection Production by Type (2018-2023) & (K Units)
Table 49. World Recombinant Human GM-CSF for Injection Production by Type (2024-2029) & (K Units)
Table 50. World Recombinant Human GM-CSF for Injection Production Value by Type (2018-2023) & (USD Million)
Table 51. World Recombinant Human GM-CSF for Injection Production Value by Type (2024-2029) & (USD Million)
Table 52. World Recombinant Human GM-CSF for Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Recombinant Human GM-CSF for Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Recombinant Human GM-CSF for Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Recombinant Human GM-CSF for Injection Production by Application (2018-2023) & (K Units)
Table 56. World Recombinant Human GM-CSF for Injection Production by Application (2024-2029) & (K Units)
Table 57. World Recombinant Human GM-CSF for Injection Production Value by Application (2018-2023) & (USD Million)
Table 58. World Recombinant Human GM-CSF for Injection Production Value by Application (2024-2029) & (USD Million)
Table 59. World Recombinant Human GM-CSF for Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Recombinant Human GM-CSF for Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Recombinant Human GM-CSF for Injection Product and Services
Table 64. Sanofi Recombinant Human GM-CSF for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. Changchun GeneScience Basic Information, Manufacturing Base and Competitors
Table 68. Changchun GeneScience Major Business
Table 69. Changchun GeneScience Recombinant Human GM-CSF for Injection Product and Services
Table 70. Changchun GeneScience Recombinant Human GM-CSF for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Changchun GeneScience Recent Developments/Updates
Table 72. Changchun GeneScience Competitive Strengths & Weaknesses
Table 73. Hainan Unipul Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Hainan Unipul Pharmaceutical Major Business
Table 75. Hainan Unipul Pharmaceutical Recombinant Human GM-CSF for Injection Product and Services
Table 76. Hainan Unipul Pharmaceutical Recombinant Human GM-CSF for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Hainan Unipul Pharmaceutical Recent Developments/Updates
Table 78. Hainan Unipul Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 80. Harbin Pharmaceutical Group Major Business
Table 81. Harbin Pharmaceutical Group Recombinant Human GM-CSF for Injection Product and Services
Table 82. Harbin Pharmaceutical Group Recombinant Human GM-CSF for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Harbin Pharmaceutical Group Recent Developments/Updates
Table 84. Guangzhou Baiyunshan Baidi Biotechnology Basic Information, Manufacturing Base and Competitors
Table 85. Guangzhou Baiyunshan Baidi Biotechnology Major Business
Table 86. Guangzhou Baiyunshan Baidi Biotechnology Recombinant Human GM-CSF for Injection Product and Services
Table 87. Guangzhou Baiyunshan Baidi Biotechnology Recombinant Human GM-CSF for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 88. Global Key Players of Recombinant Human GM-CSF for Injection Upstream (Raw Materials)
Table 89. Recombinant Human GM-CSF for Injection Typical Customers
Table 90. Recombinant Human GM-CSF for Injection Typical Distributors
LIST OF FIGURE
Figure 1. Recombinant Human GM-CSF for Injection Picture
Figure 2. World Recombinant Human GM-CSF for Injection Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Recombinant Human GM-CSF for Injection Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Recombinant Human GM-CSF for Injection Production (2018-2029) & (K Units)
Figure 5. World Recombinant Human GM-CSF for Injection Average Price (2018-2029) & (US$/Unit)
Figure 6. World Recombinant Human GM-CSF for Injection Production Value Market Share by Region (2018-2029)
Figure 7. World Recombinant Human GM-CSF for Injection Production Market Share by Region (2018-2029)
Figure 8. North America Recombinant Human GM-CSF for Injection Production (2018-2029) & (K Units)
Figure 9. Europe Recombinant Human GM-CSF for Injection Production (2018-2029) & (K Units)
Figure 10. China Recombinant Human GM-CSF for Injection Production (2018-2029) & (K Units)
Figure 11. Japan Recombinant Human GM-CSF for Injection Production (2018-2029) & (K Units)
Figure 12. Recombinant Human GM-CSF for Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 15. World Recombinant Human GM-CSF for Injection Consumption Market Share by Region (2018-2029)
Figure 16. United States Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 17. China Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 18. Europe Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 19. Japan Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 20. South Korea Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 22. India Recombinant Human GM-CSF for Injection Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Recombinant Human GM-CSF for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Human GM-CSF for Injection Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Human GM-CSF for Injection Markets in 2022
Figure 26. United States VS China: Recombinant Human GM-CSF for Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Recombinant Human GM-CSF for Injection Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Recombinant Human GM-CSF for Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Recombinant Human GM-CSF for Injection Production Market Share 2022
Figure 30. China Based Manufacturers Recombinant Human GM-CSF for Injection Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Recombinant Human GM-CSF for Injection Production Market Share 2022
Figure 32. World Recombinant Human GM-CSF for Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Recombinant Human GM-CSF for Injection Production Value Market Share by Type in 2022
Figure 34. 75ug
Figure 35. 150ug
Figure 36. World Recombinant Human GM-CSF for Injection Production Market Share by Type (2018-2029)
Figure 37. World Recombinant Human GM-CSF for Injection Production Value Market Share by Type (2018-2029)
Figure 38. World Recombinant Human GM-CSF for Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Recombinant Human GM-CSF for Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Recombinant Human GM-CSF for Injection Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Others
Figure 44. World Recombinant Human GM-CSF for Injection Production Market Share by Application (2018-2029)
Figure 45. World Recombinant Human GM-CSF for Injection Production Value Market Share by Application (2018-2029)
Figure 46. World Recombinant Human GM-CSF for Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Recombinant Human GM-CSF for Injection Industry Chain
Figure 48. Recombinant Human GM-CSF for Injection Procurement Model
Figure 49. Recombinant Human GM-CSF for Injection Sales Model
Figure 50. Recombinant Human GM-CSF for Injection Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
